Ημερολόγιο Συνεδρίων για το HIV/AIDS

February 2020
24th Healthcare Technologies and Public Health 2020 Lisbon, Portugal
26th International Conference on HIV/AIDS Prevention and Control Pretoria, South Africa
27th International Conference on Entrepreneurship, Business, Economics and Management Research MalΓ©, Maldives
27th ISBER International Conference on Teaching and Learning, Business Ethics, Management, Social Sciences & Humanities MalΓ©, Maldives
29th International Conference on African Studies Pretoria, South Africa
March 2020
23rd Euro Infectious Diseases Congress Paris, France
April 2020
16th American Conference for the Treatment of HIV Chicago, United States of America
May 2020
16th International Conference on Infectious Diseases Colombo, Sri Lanka
18th 03rd International Conference on Pharmaceutical Sciences Colombo, Sri Lanka
21st World Congress on Control and Prevention of HIV/AIDS Osaka, Japan
24th 02nd International Conference on Community Medicine and Public Health Colombo, Sri Lanka
25th 03rd International Conference on Non Communicable Diseases Colombo, Sri Lanka
28th HIV Update: Contemporary Issues in Management Boston, United States of America
August 2020
15th 3rd International Conference on Marketing Finance, HR and Social Science Barcelona, Spain
September 2020
14th International Conference on STD Prevention Las Vegas, United States of America
October 2020
19th 2nd World Nursing and Health Care Congress San Francisco, United States of America
19th Global Experts Meeting on Frontiers in Infectious Diseases Miami, United States of America
November 2020
28th 3rd International Conference on Research Methodology for Business Economics, Social Sciences and Entrepreneurial Studies Bali, Indonesia
December 2020
1st 6th Global Public Health 2020 Bali, Indonesia
16th 03rd International Conference on Women and Child Health Colombo, Sri Lanka
18th 06th International Conference on Ayurveda Traditional Medicine and Medicinal Plants Colombo, Sri Lanka
1


Lancet

Πρόσφατες δημοσιεύσεις στο περιοδικό The Lancet HIV

Influenza vaccine in pregnant women with HIV: are we there?

In The Lancet HIV, Marta Nunes and colleagues report their clinical trial assessing three different approaches to influenza vaccination in pregnant women with HIV in South Africa.1 Recognising that the standard vaccine, while licensed, might not be the best approach, they compared the safety and immunogenicity of a double dose of a seasonal vaccine to a booster dose of the vaccine with the standard dose of the same influenza vaccine. Their reasons for choosing these different approaches was because immune responses to standard vaccination in this population are poor, with downstream concerns for risk for influenza disease in both mother and baby.

Circulating resistance to first-line HIV drug regimens

Pretreatment HIV drug resistance (PDR) is increasing in sub-Saharan Africa, driven by increasing resistance to non-nucleoside reverse transcriptase inhibitor (NNRTI) drugs.1 This has led WHO to recommend that countries with a population prevalence of NNRTIs resistance greater than 10% adopt alternative first-line regimens, or consider PDR testing to guide selection of antiretroviral therapy (ART).1,2 In response, many countries in sub-Saharan Africa are now rolling out dolutegravir-based first-line ART.

On-demand PrEP efficacy: forgiveness or timely dosing

Oral daily pre-exposure prophylaxis (PrEP) containing tenofovir disoproxil fumarate plus emtricitabine can be highly protective against HIV infection. However, its effectiveness is dependent on drug intake. In large randomised placebo-controlled trials,1,2 objective measures of adherence have closely predicted the extent of protection against HIV in the intention-to-treat population (figure). The proxy for adherence was the percentage of patients for whom tenofovir was detected in plasma in all studies, with the exception of the PROUD study that used the percentage of days covered by PrEP over 2 years of follow-up.

About us

Στο hivaids.gr, φιλοξενούμε αφιλοκερδώς το "Πρόγραμμα Συνεργασίας" Μονάδων Λοιμώξεων για την ανάπτυξη διαδικτυακής τράπεζας κλινικών παραμέτρων. Το Πρόγραμμα δημιουργήθηκε από έναν γιατρό ειδικό στην HIV λοίμωξη με τη συμμετοχή των Μονάδων: Περισσότερα

% Αναπηρία και HIV

Νέος κανονισμός

Ενιαίος Πίνακας Προσδιορισμού Ποσοστού Αναπηρίας

Ημερολόγιο

@ Διαύγεια

ΔιαύγειαΔι@ύγεια

διαφάνεια στο κράτος

Διαδικτυακές αναρτήσεις διοικητικών αποφάσεων για το HIV/AIDS

Έρευνα

Σας έχει σπάσει ποτέ το προφυλακτικό κατά τη διάρκεια μιας ερωτικής επαφής;
Ναι
Όχι
Δεν χρησιμοποιώ

Επικοινωνία

Newsletter

Ανακοινώσεις

Χρήσιμες πληροφορίες